China coenzyme Q10 supply situation is directly affected by international regulations and demand.The domestic coenzyme Q10 market experienced the primary stage and firece competition stage and then the advanced enterprises survived.The pattern of China Coenzyme Q10 market is generally stable presently.
Coenzyme Q10 was allowed to applied in dietary supplements and cosmestics in Japan in 2002.FDA approved coenzyme Q10 to be used as health products in 2004.The Coenzyme Q10 market then exploded.Which stimulated interest in the development and production of coenzyme Q10. Xi'an HaoTian Bio-engineering Technology Co., Ltd is the lead enterprise in China successfully launched coenzyme Q10 with semi-synthetic method into the international market around 2004. Zhejiang Medicine Co.Ltd. is the following manufacturer with the ability to supply a bunch of coenzyme Q10 through fermentation in late 2004.Coenzyme Q10 market became hot from 2005.Many manufacturer began to product with expecting to acquire benefit.However,the international market turned down sharply before manufacturers achieve tragic goals steadily because the Japanese suppliers' price policy.
Synthetic coenzyme Q10 was forced to withdraw from the international market in 2006.Fermented coenzyme Q10 was preferred in domestic market.
The export volume of coenzyme Q10 reached over 100 tonns in 2007 and 2008 in China.The export price declined gradually to approximately 240$/kg now.The domestic coenzyme Q10 is presently dominated by great enterprises with average annual yield of over 100 tonnes.Major coenzyme Q10 suppliers in China are as follows: Xiamen Kingdomway Group, Zhejiang NHU Company Ltd., Zhejiang Medicine Co.Ltd.,Xinchang Pharmaceutical Factory,FuYang Kexing Biochem Co., Ltd,Xi'an HaoTian Bio-engineering Technology Co., Ltd。Shenzhou Bio-tech made relevent technological breakthough and acquired high efficient bacteria by space enviorment and selection tactics.They will play a great part in coenzyme sector.
——本网内容注明出处为“植物提取产业信息网”的所有文字、图片、音视频稿件均属植物提取产业信息网所有,任何媒体、网站或个人未经授权不得转载、链接、转帖或以其他方式复制发表。违反上述声明者,本网将追究其相关法律责任。
——如因信息内容、版权和其它问题需要与本网联系的,请联系我们(herbridge@163.com)。
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

